Is Moderna listed on the ASX?

Can ASX investors buy Moderna shares?

| More on:
A doctor looks unsure, indicating share price uncertainty for ASX medical companies

Image source: Getty images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Moderna has become a household name in recent years for obvious reasons
  • The company has made news today by announcing a new vaccine manufacturing hub in Victoria
  • But are Moderna shares available for ASX investors?

Is Moderna listed on the ASX? The vaccine company has become a household name over the past two years. Moderna vaccines were approved for use against COVID-19 back in August last year. Since then, countless doses have been put in arms across the country.

What's more, we got the news today that the Federal Government and the Victorian Government has partnered up with Moderna to build the first mRNA vaccine manufacturing hub in the Southern Hemisphere.

According to reporting from the ABC, the two governments will provide support for Moderna to construct a manufacturing facility in Victoria. The exact location is yet to be determined. According to the report, all parties are hoping that the new plant will produce its first vaccines "sometime in 2024". But the facility will not be restricted to just COVID vaccines. There are "plans to develop a number of other respiratory treatments and vaccines" too. These are likely to include influenza (the flu) and respiratory syncytial virus.

So now Moderna is set to have such a strong presence in Australia, many investors might be hoping to get a piece of the action in their own portfolios. So is Moderna an ASX listed share?

Are Moderna shares on the ASX?

Unfortunately, the answer is no.

Moderna is indeed a public company. But it is an American one through and through, having been founded in Massachusetts in 2010. As such, Moderna shares are listed on the US markets. Specifically, the company is on the Nasdaq exchange. Its full name is Moderna Inc (NASDAQ: MRNA). That's a highly applicable ticker code if there ever was one.

So unfortunately for ASX investors, we can't buy Moderna shares directly on the ASX. If you wanted to buy the company's shares, you would need to do so by buying the US-listed shares through a supporting broker.

Alternatively, Moderna is a constituent of both the S&P 500 Index (INDEXSP: .INX) and the NASDAQ-100 Index (NASDAQ: NDX). Both of these indexes have ASX exchange-traded funds (ETFs) that track them. So that is another avenue to explore for any aspiring Moderna investors.

But, as is the case with many global companies, there just isn't a direct ASX listing for us Aussies to go with.

The Moderna share price is currently up by 35.8% over the past 12 months, although it has taken a 24% haircut in 2022 so far. At the last Moderna share price of US$178.73, the company had a market capitalisation of US$72.03 billion.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Moderna Inc. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A smiling businessman in the city looks at his phone and punches the air in celebration of good news.
Broker Notes

These ASX 200 shares could rise 50% to 60%

Brokers believe these shares could deliver big returns for investors.

Read more »

A girl is handed an oversized ice cream cone with lots of different flavours.
Best Shares

8 ASX All Ords shares that tripled in value in FY25

Just 8 out of the 500 companies making up the ASX All Ords achieved share price growth of 200% or…

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

Woman with a scared look has hands on her face.
Broker Notes

Bapcor shares fell more than 30% yesterday. Should investors buy in the dip?

Is this a value opportunity?

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Broker Notes

Broker raises price targets on 2 ASX 200 shares to buy

Ord Minnett has just upped its 12-month share price targets on 2 buy-rated ASX 200 stocks.

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 34% on strong earnings growth

Investors just sent this ASX All Ords stock surging 34%. Here’s what’s happening.

Read more »

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
Share Fallers

Why DroneShield, Gentrack, Metals X, and Northern Star shares are tumbling today

These shares are ending the week in the red. But why?

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Gainers

Why Dimerix, Newmont, Regal Partners, and Titomic shares are storming higher

These shares are having a good finish to the week. Let's see why.

Read more »